Takuro Kobori Selected Research

moesin

7/2022	Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells.
4/2022	Ezrin Contributes to the Plasma Membrane Expression of PD-L1 in A2780 Cells.
4/2022	Ezrin Regulates the Cell Surface Localization of PD-L1 in HEC-151 Cells.
9/2021	Contribution of Ezrin on the Cell Surface Plasma Membrane Localization of Programmed Cell Death Ligand-1 in Human Choriocarcinoma JEG-3 Cells.
8/2021	Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells.
1/2021	Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuro Kobori Research Topics

Disease

9	Neoplasms (Cancer) 04/2022 - 05/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 09/2021
2	Adenocarcinoma 09/2021 - 08/2021
2	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 08/2021 - 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022
1	Ovarian Epithelial Carcinoma 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 04/2022
1	Endometrial Neoplasms (Endometrial Cancer) 04/2022
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 09/2021
1	Choriocarcinoma 09/2021
1	Carcinoma (Carcinomatosis) 09/2021
1	Diabetes Complications 12/2018
1	Renal Insufficiency (Renal Failure) 12/2018
1	Atherosclerosis 12/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018
1	Rheumatoid Arthritis 01/2018
1	Pathologic Neovascularization 01/2018
1	Pain (Aches) 01/2015
1	Cancer Pain 01/2014

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2013
6	Immune Checkpoint InhibitorsIBA 07/2022 - 08/2021
6	moesinIBA 07/2022 - 01/2021
6	ezrinIBA 04/2022 - 01/2021
5	radixinIBA 04/2022 - 01/2021
4	Immune Checkpoint ProteinsIBA 04/2022 - 08/2021
2	AntibodiesIBA 04/2022 - 09/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 01/2015
2	Opioid Analgesics (Opioids)IBA 01/2014 - 05/2013
1	B7-H1 AntigenIBA 09/2021
1	Nucleic AcidsIBA 12/2018
1	LipidsIBA 12/2018
1	Glycoproteins (Glycoprotein)IBA 12/2018
1	GlyceraldehydeIBA 12/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2018
1	glycolaldehydeIBA 12/2018
1	Advanced Glycation End ProductsIBA 12/2018
1	InterleukinsIBA 01/2018
1	Narcotics (Narcotic Analgesics)IBA 01/2015

Therapy/Procedure

4	Therapeutics 07/2022 - 08/2021
3	Drug Therapy (Chemotherapy) 09/2021 - 05/2013
2	Palliative Care (Palliative Therapy) 01/2015 - 05/2013
1	Oral Administration 01/2014